Literature DB >> 18415595

Drug therapy of pain in cancer.

G W Hanks1.   

Abstract

CONCLUSION: Most pain in cancer should be easily relieved because it responds in a predictable way to opioid analgesic drugs. Some pains do not respond so well but can usually be ameliorated by the judicious use of adjuvant analgesics, non-drug measures, and the active involvement of the multidisciplinary team.

Entities:  

Year:  1992        PMID： 18415595     DOI： 10.1007/BF02529697

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


  8 in total

Review 1.  The rational use of intrathecal and extradural opioids.

Authors:  M Morgan
Journal:  Br J Anaesth       Date:  1989-08       Impact factor: 9.166

Review 2.  Controlled-release morphine (MST Contin) in advanced cancer. The European experience.

Authors:  G W Hanks
Journal:  Cancer       Date:  1989-06-01       Impact factor: 6.860

Review 3.  Opioid-responsive and opioid-non-responsive pain in cancer.

Authors:  G W Hanks
Journal:  Br Med Bull       Date:  1991-07       Impact factor: 4.291

4.  The use of the syringe driver in terminal care.

Authors:  D J Oliver
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

Review 5.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 6.  The pharmacological treatment of bone pain.

Authors:  G W Hanks
Journal:  Cancer Surv       Date:  1988

7.  Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients.

Authors:  P Poulain; P J Hoskin; G W Hanks; O A-Omar; V A Walker; A Johnston; P Turner; G W Aherne
Journal:  Br J Anaesth       Date:  1988-11       Impact factor: 9.166

8.  Unexpected complication of successful nerve block. Morphine induced respiratory depression precipitated by removal of severe pain.

Authors:  G W Hanks; R G Twycross; J W Lloyd
Journal:  Anaesthesia       Date:  1981-01       Impact factor: 6.955
  8 in total
  1 in total

1.  Pain Challenges at the End of Life - Pain and Palliative Care Collaboration.

Authors:  Michael Platt
Journal:  Rev Pain       Date:  2010-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.